PPT Limmathurotsakul 03

advertisement
STUDY DESIGN FOR
DIAGNOSTIC STUDY FOR MELIOIDOSIS
Dr Direk Limmathurotsakul, MD MSc PhD
Introduction: 3 phases of study design
Laboratory
phase
Case-control
phase
Prospective
phase
- develop test
- test with few
cases and healthy
controls
- prove of concept
- test with definite
cases and definite
controls
- calculate
Se & Sp
- test with diseasesuspected
patients
- calculate Se, Sp,
PPV & NPV
Introduction: 3 phases of study design
Laboratory
phase
Case-control
phase
Prospective
phase
- develop test
- test with few
cases and healthy
controls
- prove of concept
- test with definite
cases and definite
controls
- calculate
Se & Sp
- test with diseasesuspected
patients
- calculate Se, Sp,
PPV & NPV
Look promising
Introduction: 3 phases of study design
Laboratory
phase
Case-control
phase
Prospective
phase
- develop test
- test with few
cases and healthy
controls
- prove of concept
- test with definite
cases and definite
controls
- calculate
Se & Sp
- test with diseasesuspected
patients
- calculate Se, Sp,
PPV & NPV
Look promising
Look good
Introduction: 3 phases of study design
Laboratory
phase
Case-control
phase
Prospective
phase
- develop test
- test with few
cases and healthy
controls
- prove of concept
- test with definite
cases and definite
controls
- calculate
Se & Sp
- test with diseasesuspected
patients
- calculate Se, Sp,
PPV & NPV
Look promising
Look good
Look rubbish
(GS problem)
Good guideline
Good guideline
• Recommendation 1: Access index test’s ability to predict
patient-relevant outcomes instead of test accuracy
• Recommendation 2: Access the concordance of difference
tests instead of test accuracy
• Recommendation 3: Qualify the interpretation of “naïve”
estimates of the index test’s performance
• Recommendation 4: Imperfect gold standard model
Recommended design for melioidosis
• Define need
For example, estimate Se, Sp, PPV and NPV in a prospective
design (to represent the real clinical situation)
• Define study population (that we would like to infer the
estimated accuracy to)
• Next: select reference standard
Recommended design for melioidosis
• If there are more than one population, at least 2 diagnostic
tests (3 tests are preferred)
Those 2 tests should be based on 2 different biological
mechanism (e.g. one antigen detection [culture] and one
antibody detection [IHA])
• If there is only one population, at least 3 diagnostic tests (5
tests are preferred)
Those 3 tests should be based on 3 different biological
mechanism (e.g. one antigen detection [culture / PCR assays],
one antibody detection [IHA/ELISA], one clinical detection
[ultrasonogram/CT scan])
Recommended design for melioidosis
• Consider repeated sampling and convalescent specimens
• Day 4 and Day 7 specimens may have clinical implication for
changing the diagnosis and treatment
• Day 14 and Day 28 specimens may have clinical implication for
starting oral treatment regimen
• Consider long-term outcome for relapse/recurrent infection
• Four-fold rising is arbitrary and based on imperfect gold
standard. This should be evaluated with better approach
• Adequate sample size is required (enough diseased patients
for sensitivity estimation is important than the total number)
Recommended design for melioidosis
•
•
•
•
•
•
•
•
•
Select sites
Appoint study team
Train staff
Provide GCP
Conduct QC and monitoring
Collect data
Perform analysis
Report results using STARD checklist
Disseminate results
END
Download
Random flashcards
Arab people

15 Cards

Radiobiology

39 Cards

Pastoralists

20 Cards

Nomads

17 Cards

Create flashcards